Promoter Aayush Agrawal, acting as the trustee for the Aayush Agrawal Trust, has notified the stock exchanges regarding changes in the pledged status of his shares in Ajanta Pharma Limited. Specifically, 2,00,000 shares were created under pledge on February 19, 2026, to secure an increased loan. Concurrently, 2,00,000 shares were released from pledge on February 17, 2026, due to the repayment of an existing loan. The disclosure confirms post-event holdings for associated promoter entities.
Disclosure of Promoter Share Encumbrance Activity
This disclosure pertains to the creation and release of pledged shares held by Promoter Aayush Agrawal, acting in his capacity as the trustee for the Aayush Agrawal Trust, in Ajanta Pharma Limited. The filing, dated 20th February, 2026, details transactions executed in line with regulatory requirements concerning shareholding changes among promoters.
Details of Pledge Transactions
The report highlights two distinct events that occurred in February 2026:
- Pledge Creation: On 19-Feb-26, 2,00,000 shares (representing 0.16% of the total share capital) were created under pledge in favor of Aditya Birla Capital Ltd. The stated reason for this creation was to facilitate an increase in loan requirements.
- Pledge Release: On 17-Feb-26, a previous pledge involving 2,00,000 shares (also 0.16%) was released from the entity’s holdings. This release was executed following a loan repayment.
Post-Event Promoter Holding Summary
Following these transactions, the holdings of key promoter entities have been updated. Aayush M Agrawal, trustee for the Aayush Agrawal Trust, now retains 82,48,407 shares, equating to 6.60% of the total share capital. Other related promoter entities, such as Yogesh M Agrawal, trustee Yogesh Agrawal Trust, continue to hold significant stakes, with the former holding 1,80,78,147 shares (14.47%).
The disclosure confirms that the transactions were recorded and acknowledged by both the BSE Limited and the National Stock Exchange of India on the reporting date.
Source: BSE
